Rare mutations account for the remaining 15% of EGFR mutations in NSCLC and include point mutations, deletions, and insertions within exons 18–25 of the EGFR gene, such as Ex20ins, G719X, S768I, and L861Q mutations [36]. Here, EGFR is linked to non-small cell lung carcinoma.